MEDS will publish its interim report for the second quarter on July 21, 2026, at 07:30 CEST. A webcast presentation will be held for analysts, media, and investors at 09:30 CEST the same day.
MEDS will publish its interim report for the second quarter on July 21, 2026, at 07:30 CEST. A webcast presentation will be held for analysts, media, and investors at 09:30 CEST the same day.
The report will be presented by Björn Thorngren, CEO and co-founder, and Nick Mendola, CFO.
The presentation will be conducted in English and broadcast live online. Please email ir@meds.se to receive a link to the live presentation (at latest 09:00 CEST on July 21).
A recorded version of the presentation will be available later at:
Rapporter och presentationer | MEDS Investor Relations
Schedule for the 21st of July:
- 07:30 CEST – Publication of the Q2 report
- 09:30 CEST – Webcast and conference call with CEO Björn Thorngren and CFO Nick Mendola
For further information, please contact:MEDS Investor RelationsE-mail: ir@meds.seWeb: https://corporate.meds.se/
About MEDSMEDS.se is a full-scale online pharmacy licensed by the Swedish Medical Products Agency. We provide both prescription and over-the-counter medicines for you, your family, and your pets.In addition, MEDS offers a wide range of products in health, beauty, and wellness.
Certified advisor is FNCA.
Attachments
Invitation to presentation of MEDS Q2 2026 Interim Report on July 21, 2026